Cancer cells being destroyed by immunotherapy.
(Source: Adobe Stock)

Discover BioVaxys’ innovative DPX™ platform, a cutting-edge lipid-based delivery system transforming immunotherapy. This video explores how the company’s proprietary technology encapsulates diverse bioactive molecules, enhancing and sustaining immune responses. Learn how BioVaxys is leveraging this groundbreaking platform to potentially revolutionize vaccines and treatments.

To keep up with the latest developments from the company, visit https://www.biovaxys.com/

This is third-party content provided by BioVaxys Technology Corp. (CSE:BIOV). Please see full disclaimer here.

Join the discussion: Find out what everybody’s saying about this company on the BioVaxys Technology Corp. Bullboard investor discussion forum, and check out the rest of Stockhouse’s stock forums and message boards.

(Top photo: Adobe Stock)


More From The Market Online
Plurilock logo

Plurilock secures $1.24M cybersecurity deal with top semiconductor manufacturer

Plurilock Security (TSXV:PLUR) announced a $1.24M contract for software licensing and professional services.

Top battery recycler taps PyroGenesis to cut emissions

PyroGenesis (TSX:PYR) signs an emissions reduction contract with one of the world's largest battery recycling companies.
Shopify

Shopify and the Santa Claus rally: A holiday opportunity?

Seasonal optimism and strong holiday sales have pushed Shopify’s (TSX:SHOP) stock up over 45 per cent year-to-date.